Diplomat Pharmacy (DPLO) Misses Q3 EPS by 22c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Diplomat Pharmacy (DPLO) PT Lowered to $18 at Mizuho Securities
November 8, 2018 10:49 AM ESTMizuho Securities analyst Ann Hynes lowered the price target on Diplomat Pharmacy (NYSE: DPLO) to $18.00 (from $23.00) while maintaining a Neutral rating.
Hynes commented, "We are updating our model and price target (now $18 from $23). Despite yesterday's sell-off driven by the disclosure of significant... More
